Cost-effectiveness of albumin in the treatment of decompensated cirrhosis in resource-limited healthcare settings

Irsan Hasan, Ignatia Sinta Murti, Putut Bayupurnama, Kemal Fariz Kalista, Christina Hill-Zabala, Dennis Kananda, Elisabet Viayna

Article Type

Original Research

Published

This study aims to assess the cost-effectiveness of human albumin in patients with cirrhosis with spontaneous bacterial peritonitis, hepatorenal syndrome or ascites requiring large-volume paracentesis in the Indonesian healthcare system as a representative of a resource-limited setting.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.